Warning letter
Vital Rx, Inc. dba Atlantic Pharmacy and Compounding: warning letter of Sep 26, 2018
FDA warning letter 539399 · Dallas District Office
Key facts
| Reference number | 539399 |
|---|---|
| Company | Vital Rx, Inc. dba Atlantic Pharmacy and Compounding |
| Subject | Drug Product/Adulterated |
| Issue date | Sep 26, 2018 |
| Posted date | Sep 26, 2018 |
| Issuing office | Dallas District Office |
| Product type | Drugs |
| Inspection city | Pompano Beach |
| Inspection ZIP | 33060 |
| Inspection start date | Jun 26, 2017 |
| Letter on fda.gov | fda.gov |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: